DanCann Pharma A/S provided revenue guidance for the year 2024. For the year, the company expected to generate approximately DKK 10 million - DKK 11 million in revenue.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.041 DKK | +7.89% | -10.48% | +36.67% |
Jun. 18 | DanCann Pharma A/S Provides Revenue Guidance for the Year 2024 | CI |
Jun. 01 | DanCann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.67% | 982K | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- DanCann Pharma A/S Provides Revenue Guidance for the Year 2024